PROFUND ADVISORS LLC – Alnylam Pharmaceuticals, Inc. Transaction History
PROFUND ADVISORS LLC portfolio value:
$2.62M
portfolio value
PROFUND ADVISORS LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.19% | -717 shares | 607K | $200.16 | 13.08K |
| Q2 2022 | share | Decrease | -7.81% | -1.17K shares | -432K | $145.85 | 13.80K |
| Q1 2022 | share | Decrease | -8.94% | -1.47K shares | -344K | $163.29 | 14.97K |
| Q4 2021 | share | Decrease | -14.66% | -2.82K shares | -850K | $171.03 | 16.44K |
| Q3 2021 | share | Decrease | -3.93% | -789 shares | 239K | $188.81 | 19.27K |
| Q2 2021 | share | Decrease | -2.68% | -552 shares | 490K | $169.52 | 20.06K |
| Q1 2021 | share | Decrease | -12.93% | -3.06K shares | -167K | $141.19 | 20.61K |
| Q4 2020 | share | Increase | +9.82% | 2.11K shares | -62K | $129.97 | 23.67K |
| Q3 2020 | share | Decrease | -13.97% | -3.50K shares | -572K | $145.6 | 21.55K |
| Q2 2020 | share | Increase | +19.63% | 4.11K shares | 1.43M | $148.11 | 25.05K |
| Q1 2020 | share | Decrease | -26.73% | -7.64K shares | -1.01M | $108.85 | 20.94K |
| Q4 2019 | share | Increase | +11.71% | 2.99K shares | 1.23M | $115.17 | 28.58K |
| Q3 2019 | share | Increase | +9.57% | 2.23K shares | 363K | $80.42 | 25.59K |
| Q2 2019 | share | Decrease | -11.36% | -2.99K shares | -767K | $72.56 | 23.35K |
| Q1 2019 | share | Increase | +6.70% | 1.65K shares | 662K | $93.45 | 26.34K |
| Q4 2018 | share | Decrease | -19.35% | -5.92K shares | -880K | $72.91 | 24.69K |
| Q3 2018 | share | Increase | +18.00% | 4.67K shares | 124K | $87.52 | 30.62K |
| Q2 2018 | share | Decrease | -4.25% | -1.15K shares | -672K | $98.49 | 25.94K |
| Q1 2018 | share | Decrease | -9.50% | -2.84K shares | -577K | $119.1 | 27.10K |
| Q4 2017 | share | Decrease | -4.78% | -1.50K shares | 110K | $127.05 | 29.94K |
| Q3 2017 | share | Increase | +1.74% | 537 shares | 1.22M | $117.49 | 31.44K |
| Q2 2017 | share | Increase | +6.09% | 1.77K shares | 973K | $79.76 | 30.91K |
| Q1 2017 | share | Decrease | -7.44% | -2.34K shares | 314K | $51.25 | 29.13K |
| Q4 2016 | share | Decrease | -13.67% | -4.98K shares | -1.29M | $37.44 | 31.48K |
| Q3 2016 | share | Decrease | -9.08% | -3.64K shares | 247K | $67.78 | 36.46K |
| Q2 2016 | share | Decrease | -4.08% | -1.70K shares | -400K | $55.49 | 40.10K |
| Q1 2016 | share | Decrease | -19.18% | -9.92K shares | -2.24M | $62.77 | 41.81K |